Rapidly destructive Staphylococcus epidermidis endocarditis

Infection

Volumn 33, Issue 3, 2005, Pages 148-150

  Zinkernagel, A S ^a   Speck, R F ^a   Ruef, C ^a   Zingg, W ^a   Berger Bachi, B ^b   Springer, B ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; DALFOPRISTIN PLUS QUINUPRISTIN; LEVOFLOXACIN; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL GROWTH; BLOOD CULTURE; CASE REPORT; CATHETER; COUGHING; DISEASE COURSE; FEVER; HEART FAILURE; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MITRAL VALVE REPLACEMENT; MOLECULAR PHYLOGENY; MYXOMA; POSTOPERATIVE PERIOD; PULSED FIELD GEL ELECTROPHORESIS; REOPERATION; STAPHYLOCOCCUS EPIDERMIDIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT FAILURE; VEGETATION;

ADULT; ANTI-BACTERIAL AGENTS; DISEASE PROGRESSION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENDOCARDITIS, BACTERIAL; HUMANS; MALE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 21144436566     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-005-4111-7     Document Type: Article

References (18)

1. Etienne J, Eykyn SJ: Increase in native valve endocarditis caused by coagulase negative staphylococci: an Anglo-French clinical and microbiological study. Br Heart J 1990; 64: 381-384.
2. Vandenesch F, Etienne J, Reverdy ME, Eykyn SJ: Endocarditis due to Staphylococcus lugdunensis: report of 11 cases and review. Clin Infect Dis 1993; 17: 871-876.
3. Fleisch F, Zbinden R, Vanoli C, Ruef C: Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland. Clin Infect Dis 2001; 32: 581-586.
4. Miele PS, Kogulan PK, Levy CS, Goldstein S, Marcus KA, Smith MA, Rosenthal J, Croxton M, Gill VJ, Lucey DR: Seven cases of surgical native valve endocarditis caused by coagulase-negative staphylococci: an underappreciated disease. Am Heart J 2001; 142: 571-576.
5. Chu VH, Cabell CH, Abrutyn E, Corey GR, Hoen B, Miro JM, Olaison L, Strjewski ME, Pappas P, Anstrom KJ, Eykyn S, Habib G, Benito N, Fowler VGJ, Group ICoEMDS: Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the international collaboration on endocarditis merged database. Clin Infect Dis 2004; 39: 1527-1530.
6. Caputo G, Archer G, Calderwood S, DiNubile M, Karchmer A: Native valve endocarditis due to coagulase-negative staphylococci. Clinical and microbiologic features. Am J Med 1987; 83: 619-625.
7. Vandecasteele SJ, Peetermans WE, Carbonez A, Van Eldere J: Metabolic activity of Staphylococcus epidermidis is high during initial and low during late experimental foreign-body infection. J Bacteriol 2004; 186: 2236-2239.
8. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318-1322.
9. Gotz F: Staphylococcus and biofilms. Mol Microbiol 2002; 43: 1367-1378.
10. Cavenaghi LA, Biganzoli E, Danese A, Parenti F: Diffusion of teicoplanin and vancomycin in agar. Diagn Microbiol Infect Dis 1992; 15: 253-258.
11. Tenover FC, Lancaster MV, Hill BC, Steward CD, Stocker SA, Hancock GA, O'Hara CM, McAllister SK, Clark NC, Hiramatsu K: Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol 1998; 36: 1020-1027.
12. Biavasco F, Vignaroli C, Varaldo PE: Glycopeptide resistance in coagulase-negative staphylococci. Eur J Clin Microbiol Infect Dis 2000; 19: 403-417.
13. Peck KR, Kim SW, Jung SI, Kim YS, Oh WS, Lee JY, Jin JH, Kim S, Song JH, Kobayashi H: Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidis. Chemotherapy 2003; 49: 189-193.
14. Evans RC, Holmes CJ: Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer. Antimicrob Agents Chemother 1987; 31: 889-894.
15. O'Neill AJ, Cove JH, Chopra I: Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. J Antimicrob Chemother 2001; 47: 647-650.
16. Parsek MR, Singh PK: Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 2003; 57: 677-701.
17. Mickelsen PA, Plorde JJ, Gordon KP, Hargiss C, McClure J, Schoenknecht FD, Condie F, Tenover FC, Tompkins LS: Instability of antibiotic resistance in a strain of Staphylococcus epidermidis isolated from an outbreak of prosthetic valve endocarditis. J Infect Dis 1985; 152: 50-58.
18. Gander S, Finch R: The effects of exposure at constant (1 h) or exponentially decreasing concentrations of quinupristin/dalfopristin on biofilms of gram-positive bacteria. J Antimicrob Chemother 2000; 46: 61-67.